| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 1062 | 19 | 991 | 108 | 1315 | 188 | 1144 |
| ERLYTX | 78 | 1 | 52 | 2 | 24 | 6 | 37 |
| GI | 187 | 3 | 157 | 15 | 183 | 23 | 140 |
| GU | 406 | 5 | 261 | 24 | 292 | 46 | 280 |
| LEUK | 136 | 3 | 157 | 8 | 97 | 17 | 103 |
| LUNG | 181 | 6 | 313 | 19 | 231 | 32 | 195 |
| LYMPH | 391 | 11 | 574 | 38 | 463 | 57 | 347 |
| MELAN | 246 | 0 | 0 | 0 | 0 | 0 | 0 |
| MMYEL | 118 | 1 | 52 | 6 | 73 | 11 | 67 |
| MULT | 23 | 0 | 0 | 0 | 0 | 1 | 6 |
| OTHER | 43 | 1 | 52 | 4 | 49 | 8 | 49 |
| PREV | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| SXQOL | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2875 | 50 | 2609 | 224 | 2727 | 389 | 2368 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 1 | 1 | 52 | 1 | 12 | 1 | 6 | |
| CCD | 125 | 5 | 261 | 18 | 219 | 31 | 189 |
| ERLYTX | 10 | 0 | 0 | 0 | 0 | 0 | 0 |
| GU | 1 | 0 | 0 | 1 | 12 | 1 | 6 |
| LEUK | 620 | 10 | 522 | 51 | 621 | 97 | 590 |
| LUNG | 332 | 9 | 470 | 34 | 414 | 57 | 347 |
| OTHER | 35 | 0 | 0 | 1 | 12 | 2 | 12 |
| PEOLC | 121 | 0 | 0 | 1 | 12 | 6 | 37 |
| PREV | 226 | 3 | 157 | 22 | 268 | 39 | 237 |
| SXQOL | 572 | 14 | 730 | 46 | 560 | 81 | 493 |
| Total | 2043 | 42 | 2192 | 175 | 2130 | 315 | 1917 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 1 | 1 | 52 | 1 | 12 | 1 | 6 | |
| BREAST | 1062 | 19 | 991 | 108 | 1315 | 188 | 1144 |
| CCD | 125 | 5 | 261 | 18 | 219 | 31 | 189 |
| ERLYTX | 88 | 1 | 52 | 2 | 24 | 6 | 37 |
| GI | 187 | 3 | 157 | 15 | 183 | 23 | 140 |
| GU | 407 | 5 | 261 | 25 | 304 | 47 | 286 |
| LEUK | 756 | 13 | 678 | 59 | 718 | 114 | 694 |
| LUNG | 513 | 15 | 783 | 53 | 645 | 89 | 542 |
| LYMPH | 391 | 11 | 574 | 38 | 463 | 57 | 347 |
| MELAN | 246 | 0 | 0 | 0 | 0 | 0 | 0 |
| MMYEL | 118 | 1 | 52 | 6 | 73 | 11 | 67 |
| MULT | 23 | 0 | 0 | 0 | 0 | 1 | 6 |
| OTHER | 78 | 1 | 52 | 5 | 61 | 10 | 61 |
| PEOLC | 121 | 0 | 0 | 1 | 12 | 6 | 37 |
| PREV | 228 | 3 | 157 | 22 | 268 | 39 | 237 |
| SXQOL | 574 | 14 | 730 | 46 | 560 | 81 | 493 |
| Total | 4918 | 92 | 4800 | 399 | 4857 | 704 | 4286 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 684 | 12 | 626 | 77 | 937 | 135 | 822 |
| ERLYTX | 44 | 1 | 52 | 1 | 12 | 3 | 18 |
| GI | 134 | 1 | 52 | 10 | 122 | 14 | 85 |
| GU | 338 | 4 | 209 | 17 | 207 | 38 | 231 |
| LEUK | 83 | 2 | 104 | 7 | 85 | 13 | 79 |
| LUNG | 114 | 3 | 157 | 13 | 158 | 22 | 134 |
| LYMPH | 252 | 7 | 365 | 22 | 268 | 37 | 225 |
| MELAN | 155 | 0 | 0 | 0 | 0 | 0 | 0 |
| MMYEL | 73 | 1 | 52 | 2 | 24 | 6 | 37 |
| MULT | 8 | 0 | 0 | 0 | 0 | 0 | 0 |
| OTHER | 43 | 1 | 52 | 4 | 49 | 8 | 49 |
| PREV | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| SXQOL | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1932 | 32 | 1669 | 153 | 1862 | 276 | 1680 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 1 | 1 | 52 | 1 | 12 | 1 | 6 | |
| CCD | 110 | 5 | 261 | 16 | 195 | 27 | 164 |
| ERLYTX | 10 | 0 | 0 | 0 | 0 | 0 | 0 |
| GU | 1 | 0 | 0 | 1 | 12 | 1 | 6 |
| LEUK | 263 | 5 | 261 | 19 | 231 | 37 | 225 |
| LUNG | 209 | 5 | 261 | 18 | 219 | 32 | 195 |
| OTHER | 35 | 0 | 0 | 1 | 12 | 2 | 12 |
| PEOLC | 86 | 0 | 0 | 1 | 12 | 5 | 30 |
| PREV | 226 | 3 | 157 | 22 | 268 | 39 | 237 |
| SXQOL | 391 | 9 | 470 | 33 | 402 | 58 | 353 |
| Total | 1332 | 28 | 1462 | 112 | 1363 | 202 | 1228 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 1 | 1 | 52 | 1 | 12 | 1 | 6 | |
| BREAST | 879 | 17 | 887 | 96 | 1169 | 169 | 1029 |
| CCD | 144 | 4 | 209 | 15 | 183 | 29 | 177 |
| ERLYTX | 54 | 1 | 52 | 1 | 12 | 3 | 18 |
| GI | 138 | 1 | 52 | 9 | 110 | 14 | 85 |
| GU | 361 | 4 | 209 | 22 | 268 | 43 | 262 |
| LEUK | 346 | 7 | 365 | 26 | 317 | 50 | 304 |
| LUNG | 330 | 8 | 417 | 33 | 402 | 60 | 365 |
| LYMPH | 252 | 7 | 365 | 22 | 268 | 37 | 225 |
| MELAN | 155 | 0 | 0 | 0 | 0 | 0 | 0 |
| MMYEL | 66 | 1 | 52 | 2 | 24 | 6 | 37 |
| MULT | 28 | 0 | 0 | 3 | 37 | 5 | 30 |
| OTHER | 243 | 3 | 157 | 10 | 122 | 24 | 146 |
| PEOLC | 89 | 1 | 52 | 2 | 24 | 6 | 37 |
| PREV | 228 | 3 | 157 | 22 | 268 | 39 | 237 |
| SXQOL | 393 | 9 | 470 | 33 | 402 | 58 | 353 |
| Total | 3707 | 67 | 3496 | 297 | 3618 | 544 | 3311 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 876 | 17 | 887 | 83 | 1011 | 145 | 883 |
| ERLYTX | 74 | 1 | 52 | 2 | 24 | 6 | 37 |
| GI | 109 | 2 | 104 | 10 | 122 | 15 | 91 |
| GU | 249 | 4 | 209 | 18 | 219 | 36 | 219 |
| LEUK | 102 | 2 | 104 | 4 | 49 | 9 | 55 |
| LUNG | 147 | 6 | 313 | 17 | 207 | 27 | 164 |
| LYMPH | 317 | 7 | 365 | 29 | 353 | 44 | 268 |
| MMYEL | 104 | 0 | 0 | 5 | 61 | 8 | 49 |
| MULT | 23 | 0 | 0 | 0 | 0 | 1 | 6 |
| Total | 2001 | 39 | 2034 | 168 | 2046 | 291 | 1772 |
| Inst. | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| Member | 1906 | 34 | 1774 | 154 | 1875 | 276 | 1680 |
| AFFIL | 141 | 0 | 0 | 15 | 183 | 28 | 170 |
| CCOP/NCORP | 1217 | 26 | 1357 | 96 | 1169 | 174 | 1059 |
| Non-SWOG | 1654 | 32 | 1670 | 134 | 1631 | 226 | 1376 |
| Total | 4918 | 92 | 4801 | 399 | 4858 | 704 | 4285 |
| ADMIN | STUDYID | STNAME | REGTYPE | Opened? | Open Date |
|---|---|---|---|---|---|
| ERLYTX | SN2426 | cSCC, IC Met/Inop, Amivantamab v Cetuximab | 1 | Y | 28-JAN-26 |
| ADMIN | STUDYID | STNAME | REGTYPE | Opened? | Open Date |
|---|---|---|---|---|---|
| GU | S2210 | Pros, High Risk, BRCA, Neoadj Carbo | 1 | T | 21-JAN-26 |
| GU | S2200 | pRCC, Adv, Cabo ± Atezo | 1 | T | 16-JAN-26 |
| OTHER | NRGBN011 | Brain, Lomustine + Temo vs Temo | 1 | E | 12-FEB-26 |
| OTHER | NRGBN011 | Brain, Lomustine + Temo vs Temo | 2 | E | 12-FEB-26 |
| OTHER | A071701 | BRAIN, Met, Geno-guided trial | 0 | E | 05-FEB-26 |
| OTHER | A071701 | BRAIN, Met, Geno-guided trial | 1 | E | 05-FEB-26 |
| ADMIN | STUDYID | STNAME | REGTYPE | Registrations |
|---|---|---|---|---|
| BREAST | S2206 | Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva | 1 | 15 |
| BREAST | S2212 | Breast, TNBC, Neoadj Chemo + Pembro | 1 | 14 |
| LEUK | MYELOMATCH | MSRP for the NCI myeloMATCH Clinical Trials | 1 | 10 |
| LUNG | LUNGMAP | NSCLC, Adv, Master | 1 | 9 |
| SXQOL | S2013 | I-CHECKIT: ICI toxicity risk prediction study | 1 | 9 |
| LEUK | MYELOMATCH | MSRP for the NCI myeloMATCH Clinical Trials | 2 | 8 |
| LUNG | LUNGMAP | NSCLC, Adv, Master | 2 | 5 |
| SXQOL | S2205 | ICE COMPRESS: Reduction of CIPN from Taxanes | 1 | 5 |
| LYMPH | S2308 | FL, LTB, Mosunetuzumab vs Rituximab | 1 | 4 |
| CCD | S2417CD | Colrec Surv, Follow-up w/ CTAC site | 1 | 4 |
| LYMPH | AHOD2131 | cHL,StgI-II,StdTherapyvImmuno-oncologyTherapy | 1 | 3 |
| BREAST | S2206 | Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva | 2 | 3 |